๐ŸŽ Black Friday: up to 50% off of annual plans
Xspray Pharma AB (publ) (STO:XSPRAY)
Sweden flag Sweden ยท Delayed Price ยท Currency is SEK
10.18
-0.30 (-2.86%)
Nov 20, 2026, 5:29 PM CET

Xspray Pharma AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
7.192.47----
Revenue Growth
25.16%-----
Gross Profit
7.192.47----
Operating Income
-135.34-159.13-283.24-180.77-131.38-96.95
Net Income
-151.44-171.44-285.52-179.67-131.67-96.7
Earnings Per Share
-3.43-4.46-8.62-6.76-6.25-5.03
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
88.84153.75208.24166.3120.17271.88
Total Debt
96.34148.39128.2236.812.133.23
Net Cash (Debt)
-7.55.3580.02129.5118.04268.65
Net Cash Growth
--93.31%-38.21%9.70%-56.06%-16.23%
Net Cash Per Share
-0.170.142.414.875.6013.96

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-142.37-193.16-222.37-203.28-110.18-51.61
Capital Expenditures
---4.38-2.69-24.47-1.31
Free Cash Flow
-142.37-193.16-226.75-205.97-134.65-52.92
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%----
Operating Margin
-1882.85%-6453.12%----
Pretax Margin
-2107.75%-6956.49%----
Profit Margin
-2106.87%-6952.27%----
FCF Margin
-1980.61%-7833.05%----

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-3.762.022.6214.5314.53
PS Ratio
67.15532.36----